-
Product Insights
Amblyopia Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Amblyopia Global Clinical Trials Review, H1, 2017" provides an overview of Amblyopia clinical trials scenario. This report provides top line data relating to the clinical trials on Amblyopia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Anterior Uveitis Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Anterior Uveitis Global Clinical Trials Review, H1, 2017" provides an overview of Anterior Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Anterior Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Bacterial Conjunctivitis Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Bacterial Conjunctivitis Global Clinical Trials Review, H1, 2017" provides an overview of Bacterial Conjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Bacterial Conjunctivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Blepharitis Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Blepharitis Global Clinical Trials Review, H1, 2017" provides an overview of Blepharitis clinical trials scenario. This report provides top line data relating to the clinical trials on Blepharitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Blepharospasm Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Blepharospasm Global Clinical Trials Review, H1, 2017" provides an overview of Blepharospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Blepharospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
EpiCast Report: Macular Edema – Epidemiology Forecast to 2026
Macular edema (ME) is a condition characterized by the thickening and swelling (edema) of the macula, which is the area of the retina that is responsible for central vision. The occurrence of ME is highly frequent in diabetics and usually manifests itself as diabetic macular edema (DME). The risk for ME is also higher in patients with retinal vein occlusion (RVO), which consists of two types: branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). GlobalData’s epidemiological analysis...
-
Sector Analysis
PharmaPoint: Macular Edema – Global Drug Forecast and Market Analysis to 2026
ME is a condition characterized by the thickening and swelling (edema) of the macula, which is the area of the retina that is responsible for central vision. The occurrence of ME is highly frequent in diabetics and usually manifests itself as DME, a complication of diabetic retinopathy, and is the most common cause of vision loss in patients affected by diabetes mellitus. In addition the risk for ME is also higher in patients with retinal vein occlusion, a common condition...
-
Sector Analysis
EpiCast Report: Age-Related Macular Degeneration – Epidemiology Forecast to 2026
Age-related macular degeneration (AMD) is a progressive eye condition that is characterized by the gradual deterioration of the macula, which is the area of the retina responsible for central vision. AMD is the most common cause of significant irreversible vision loss among the elderly. GlobalData epidemiologists utilized national databases and robust peer-reviewed journal articles to build the forecast for the total prevalent cases (including both diagnosed and undiagnosed) as well as the diagnosed incident cases of AMD, early AMD, late...
-
Sector Analysis
OpportunityAnalyzer: Uveitis Opportunity Analysis and Forecasts to 2026
Uveitis is an inflammatory condition of the eye affecting mainly the uvea. It encompasses a heterogeneous collection of disorders characterized by ocular inflammation. Currently, there is only a limited number of approved drugs for the treatment of uveitis. Based on the diverse nature of uveitis , there is a high unmet need for varied therapy approaches. Significant efforts are being made to develop new treatments for uveitis, as current pharmacologic management, which is dominated by competitively priced corticosteroids and also...
-
Product Insights
Macular Degeneration Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Macular Degeneration Global Clinical Trials Review, H2, 2017" provides an overview of Macular Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.